Trials / Recruiting
RecruitingNCT07319442
CEDUR - German IBD Registry
Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- ImmunoRegister gUG · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Detailed description
CEDUR is a multicenter, web-based, observational registry for adult IBD patients in Germany. The registry includes Crohn's disease, ulcerative colitis, and indeterminate colitis. Data are collected prospectively from physicians and patients, covering clinical parameters, quality of life, treatment patterns, and safety outcomes. The registry supports the evaluation of care quality, cost-effectiveness, and long-term therapy outcomes under real-life conditions.
Conditions
Timeline
- Start date
- 2018-05-03
- Primary completion
- 2036-05-01
- Completion
- 2036-05-01
- First posted
- 2026-01-06
- Last updated
- 2026-01-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07319442. Inclusion in this directory is not an endorsement.